VETSULIN®

VETSULIN^®

Canine Endocrine Products

Product Description

VETSULIN^® (porcine insulin zinc suspension) is for the treatment of diabetes mellitus in dogs. VETSULIN^® is the only veterinary insulin that is FDA-approved for both dogs and cats.

Read Label Get Training

Product Name	Pkg Size	GTIN#/UPC#	UIN#
VETSULIN^® (porcine insulin zinc suspension)	10 X 2.7 ml	8713184113597	139942
VETSULIN^® (porcine insulin zinc suspension) (5 bottles/box)	1 X 10ml	021784046855	127260
VETSULIN^® U-40 Insulin Syringes 0.5 mL	100 X 0.5 ml x 29g		164948
VETSULIN^® U-40 Insulin Syringes 1 mL	100 x 1ml		164452

Images

VETSULIN® (porcine insulin zinc suspension)

VETSULIN® (porcine insulin zinc suspension) (5 bottles/box)

VETSULIN® U-40 Insulin Syringes 0.5 mL

VETSULIN® U-40 Insulin Syringes 1 mL

The #1 recommended insulin for dogs

Choose it for life

More convenient and accurate dosing

VETSULIN® Logos

Collateral

Tracking an Uptick in Equine Influenza

Fall 2015: The most recent six months of Biosurveillance data reveal equine influenza virus (EIV) as the most common pathogen. Interesting demographic factors observed among EIV positive cases.

Disease Trends, Case Demographics Underscore Importance of Good Biosecurity

Spring 2016: Surprising trends take shape in eighth year of the Respiratory Biosurveillance Program. Why sound biosecurity measures are more important than ever.

Focus on Diagnostics: The Important Role You Play in Monitoring Disease Trends

Summer 2016: Disease trends from January to June 2016. Respiratory Surveillance questionnaire. The importance of collecting accurate samples.

Spotlight on Equine Herpesvirus-4

Spring 2017: Study confirms equine herpesvirus-4 (EHV-4) is a predominant virus associated with upper airway infection.

Getting to Know the “Other” Herpesviruses

Fall 2017: What we know about the gamma herpesviruses, equine herpesviruses types 2 and 5 (EHV-2, EHV-5). There is some evidence suggesting that EHV-2 and EHV-5 may be clinically important as respiratory and ocular pathogens in some situations.

How the Biosurveillance Program Delivered the Industry’s Most Current Influenza Vaccine Protection

Spring 2018: In February 2013, an outbreak of equine herpesvirus (EHV-1) and equine influenza virus (EIV) impacted a large number of well-vaccinated horses. How the Florida ’13 vaccine strain story began.

Putting a Chokehold on Strangles

Fall 2018: Biosurveillance Program sheds light on Streptococcus equi subs. equi (better known as strangles), prevalence factors.

Equine Respiratory Biosurveillance Program: 10 Years Later

Spring 2019: Infectious respiratory disease outbreaks have played an often too visible role in the horse industry and the costs have been staggering.

From Outbreak to Vaccine: A True Tale of Equine Influenza Surveillance

Fall 2019: A silver lining in an equine influenza outbreak? Thanks to real world surveillance we can learn from an outbreak by isolating and sequencing the strain causing it to potentially improve vaccine protection.

Respiratory Case Study: Influenza in a Training Barn Without Testing, How Do You Know?

Spring 2020: The most powerful aspect of the Equine Respiratory Biosurveillance Program is the data—the diagnostic results delivered within 24 hours to provide crucial evidence-based guidance in dealing with a sick horse infected with an upper-respiratory disease agent

Important Safety Information

VETSULIN^® (porcine insulin zinc suspension): VETSULIN^® should not be used in dogs or cats known to have a systemic allergy to pork or pork products. VETSULIN^® is contraindicated during periods of hypoglycemia. Keep out of reach of children. As with all insulin products, careful patient monitoring for hypoglycemia and hyperglycemia is essential to attain and maintain adequate glycemic control and prevent associated complications. Over dosage can result in profound hypoglycemia and death. The safety and effectiveness of VETSULIN^® in puppies and kittens and in breeding, pregnant, and lactating dogs and cats have not been evaluated. See package insert for full information regarding contraindications, warnings, and precautions.